A Phase I Study of High-Dose Interleukin-2 in Combination with Interferon-α2b
Phase I Trial of Continuous Infusion Recombinant Interleukin-2 and Intermittent Recombinant Interferon-α2a : Clinical Effects
Immunotherapy with Lymphokine-Activated Natural Killer Cells and Recombinant Interleukin-2 : A Feasibility Trial in Metastatic Renal Cell Carcinoma
Recombinant α-Interferon Enhances Tumor Targeting of an Antimelanoma Monoclonal Antibody In Vivo
Priming Effect of Orally Administered Muramyl Dipeptide on Induction of Endogenous Tumor Necrosis Factor
Interferon Protects Normal Human Granulocyte/Macrophage Colony-Forming Cells from Ara-C Cytotoxicity
Effects of Granulocyte Colony-Stimulating Factor on Hematopoietic Injury Induced by Anticancer Drugs in Mice
Phase II Evaluation of Recombinant γ-Interferon in Patients with Advanced Pancreatic Carcinoma : A Southwest Oncology Group Study
A Phase II Trial of Recombinant Tumor Necrosis Factor in Patients with Metastatic Colorectal Adenocarcinoma : A Southwest Oncology Group Study
Receptors for Human Plasminogen on the Biological Response Modifier OK-432
Announcement